跳至主要内容
临床试验/NCT05039697
NCT05039697已完成不适用

Normobaric Hyperoxia Combined with Endovascular Therapy in Patients with Stroke Within 6 Hours of Onset:longterm Outcome Analysis

Capital Medical University1 个研究点 分布在 1 个国家目标入组 282 人开始时间: 2021年4月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
282
试验地点
1
主要终点
Modified Rankin Scale

研究概览

简要总结

The overall incidence of good outcome for AIS following endovascular treatment is only proximately 50%. Whether NBO was safe and effective to improve acute ischemic stroke prognosis is still unclear. The investigators' hypothesis is thatNBO is a safe and effective strategy to improve longterm outcome in AIS patients undergoing endovascular treatment.

详细描述

NBO therapy is to deliver high flow oxygen (10L/min) through an oxygen storage mask. This treatment should be started in the emergency room immediately after the patient is randomized into the group, and oxygen should be continued for 4 hours.

In previous clinical studies of NBO, patients who have not receive revascularization often choose NBO for 8 hours, and studies have concluded that oxygen inhalation for more than 10 hours may bring about the risk of oxygen poisoning. However, a too short treatment time may not bring benefits. Secondly, ideally, we want to ensure that stroke patients receive NBO treatment before achieving reperfusion to protect the ischemic brain tissue, and add 1-2 hours after reperfusion. In the clinical environment after the patient arrives in the emergency department, it takes 2-3 hours to complete the revascularization process. Therefore, we believe that 4 hours of oxygen inhalation is reasonable. And our single-center study also supports that NBO treatment for 4 hours is beneficial.

The specific content is as follows: In the emergency room, patients who are assessed for suspected large blood vessels of acute anterior circulation will be randomized after signing the informed consent. If the subject is randomly divided into NBO+ET group, by putting the patient on Oxygen mask, and then immediately give oxygen (10L/min). NBO treatment is no later than half an hour after randomization. Oxygen comes from the hospital's oxygen center and is transported through wall pipes (oxygen concentration: 100%). The oxygen mask and the wall oxygen are connected by a 1.5 meter long oxygen pipe. When the patient is transferred to the operating room, we provide oxygen through a portable oxygen cylinder (capacity: 4L). In addition, in the operating room and intensive care unit, patients continue to be given wall oxygen therapy until the oxygen inhalation lasts for 4 hours. The arterial blood gas was drawn after 4 hours of oxygen inhalation. The control group directly inhales room air through the patient's nasal cavity without using any equipment. At the same time, patients in the control group were also drawn blood gas analysis at corresponding time points (approximately 4 hours after randomization).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years old.
  • The clinical symptoms and signs are consistent with acute anterior circulation large vessel occlusion;
  • NIHSS score ≥ 10 points;
  • (Level of consciousness) NIHSS score 0 or 1;
  • The time from onset to randomization is within 6 hours of onset;
  • The mRS score before stroke is 0-1;
  • The patient has good compliance and can complete the operation with local anesthesia;
  • The patient can cooperate with this study and follow-up in the future
  • Patient and family members sign informed consent。-

排除标准

  • Rapid neurological function improvement, NIHSS score less than 10 points, or evidence of vessel recanalization prior to randomization;
  • Seizures at stroke onset;
  • Intracranial hemorrhage;
  • Symptoms suggestive of subarachnoid hemorrhage, even if CT scan was normal;
  • Platelet count of less than 100,000 per cubic millimeter;
  • Severe hepatic or renal dysfunction;
  • Active and chronic obstructive pulmonary disease or acute respiratory distress syndrome;
  • >3 L/min oxygen required to maintain peripheral arterial oxygen saturation (SaO2) 95% as per current stroke management guidelines;
  • Medically unstable;
  • Life expectancy<90 days;
  • Evidence of intracranial tumor;

结局指标

主要结局

Modified Rankin Scale

时间窗: 1 year ± 30 days after randomization

the mRs is an ordinal disability score of 7 categories (0=no symptoms to 5=severe disability,and 6=death)

次要结局

  • EuroQol- 5 Dimension (EQ-5D)(1 year ± 30 days after randomization)
  • The proportion of good prognosis(1 year ± 30 days after randomization)
  • Functional independence(1 year ± 30 days after randomization)
  • The Proportion of mRS 0-3(1 year ± 30 days after randomization)
  • All-cause mortality(1 year ± 30 days after randomization)
  • Barthel Index (BI)(1 year ± 30 days after randomization)
  • New major vascular events(1 year ± 30 days after randomization)
  • kaplan-meier curve(1 year ± 30 days after randomization)

研究者

发起方
Capital Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ji Xunming,MD,PhD

Principal Investigator

Capital Medical University

研究点 (1)

Loading locations...

相似试验